Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.9M Buy
404,192
+386,135
+2,138% +$41.5M 0.02% 892
2026
Q1
$1.85M Sell
18,057
-63,809
-78% -$6.5M ﹤0.01% 3942
2025
Q4
$8.23M Buy
+81,866
New +$8.07M ﹤0.01% 2471
2025
Q2
Sell
-81,914
Closed -$5.81M 6194
2025
Q1
$5.81M Sell
81,914
-99,292
-55% -$7.76M ﹤0.01% 2712
2024
Q4
$14.2M Buy
181,206
+854
+0.5% +$79.8K 0.01% 1825
2024
Q3
$18.5M Buy
180,352
+152,465
+547% +$12.6M 0.01% 1622
2024
Q2
$2.12M Sell
27,887
-2,846
-9% -$202K ﹤0.01% 3495
2024
Q1
$2.31M Sell
30,733
-9,431
-23% -$751K ﹤0.01% 3606
2023
Q4
$2.96M Buy
+40,164
New +$2.49M ﹤0.01% 3262
2023
Q2
Sell
-57,633
Closed -$1.5M 6513
2023
Q1
$1.5M Sell
57,633
-159,523
-73% -$4.72M ﹤0.01% 3709
2022
Q4
$6.47M Buy
217,156
+60,993
+39% +$1.7M ﹤0.01% 2582
2022
Q3
$3.04M Sell
156,163
-103,626
-40% -$1.73M ﹤0.01% 3380
2022
Q2
$3.52M Buy
+259,789
New +$2.75M ﹤0.01% 3148

Other funds holding NUVL

Israel Englander's NUVL Position: Q2 2026 in Review

Israel Englander increased its Nuvalent (NUVL) stake by 2,138% in Q2 2026, buying an estimated $41.5M and bringing the position to 404,192 shares worth $49.9M. The position accounts for 0.02% of the portfolio, ranked #892.

Israel Englander first reported a position in NUVL in Q2 2022 and has held it in 13 quarters since. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Israel Englander held 404,192 shares of Nuvalent worth $49.9M as of Q2 2026.
  • Israel Englander bought 386,135 Nuvalent shares in Q2 2026, an estimated $41.5M.
  • Nuvalent made up 0.02% of Israel Englander's portfolio in Q2 2026, its #892 holding.
  • Israel Englander first reported a position in Nuvalent in Q2 2022 and has held it in 13 quarters since.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.